Key result
Treatment with the BK channel activator isopimaric acid significantly improved compound action potential amplitudes (median 5.56 mV vs 0.2 mV, p<0.01) and motor function in rats with acute spinal cord injury.
Why the study?
Spinal cord injury causes neuronal and glial cell death driven by uncontrolled Ca2+ entry and excitotoxicity, prompting investigation into whether activating BK channels with isopimaric acid provides neuroprotection.
Does isopimaric acid improve myelination, electrophysiology, and motor function in a rat model of acute spinal cord injury?
Does isopimaric acid improve myelination, electrophysiology, and motor function in a rat model of acute spinal cord injury?
Absolute Event Rate: 5.56% vs 0.2%
p-value: p=<0.01
Activation of the BK channel with isopimaric acid during acute spinal cord injury in rats preserves myelinated axonal tracts and improves electrophysiological and motor function.
May support BK channel activation in spinal cord injury models; leaves open translation to human trials.
Context/Objectives: Spinal cord injury (SCI) results in significant neuronal and glial cell death resulting in impaired neurological and motor function. Uncontrolled Ca2+ entry results in excitotoxicity and cell death. In this study, we examine the use of a BK channel activator, Isopimaric acid (ISO), as a neuroprotective agent post SCI as this channel is involved in regulating Ca2+ entry. Design: By using a 25-g clip compression at the T6 level, we generated a SCI event in wistar rats. At 1 hour post injury we administered ISO (BK channel activator), the BK channel inhibitor iberiotoxin (IbTx), or a vehicle control for 4 weeks via mini osmotic pump (pump capacity). For 8 weeks post injury, gait analysis of motor function was performed. At the end of 8 weeks, the extent of myelination in the spinal cord was assessed in addition to the electrophysiological profile. Results: Our immunohistological data suggests that ISO treatment leads to an increase or preservation of myelinated axonal tracts. This was further supported by our electrophysiological studies which demonstrate higher compound action potential amplitudes and speed of transmission in ISO-treated animals compared to inj-non-treated. Finally, treatment with ISO significantly improved motor function in our test model. Conclusion: In conclusion, activation of the BK channel during acute SCI may be a novel therapeutic target for acute SCI.
No takes yet. Share an insight, caveat, or question.
Jacobsen et al. (2018) studied Acute Spinal Cord Injury (n=34). Isopimaric acid (ISO) vs. Vehicle control (Injured-non-treated) was evaluated on Compound action potential (CAP) amplitude (p=<0.01). Treatment with the BK channel activator isopimaric acid significantly improved compound action potential amplitudes (median 5.56 mV vs 0.2 mV, p<0.01) and motor function in rats with acute spinal cord injury.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: